Clinical-severity staging system for oropharyngeal cancer: Five-year survival rates

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 10, 1997, Pages 1118-1124

  Pugliano, Frederic A ^a   Piccirillo, Jay F ^a,b   Zequeira, Maria R ^a   Emami, Bahman ^a   Perez, Carlos A ^a   Simpson, Joseph R ^a   Fredrickson, John M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8115 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PROGNOSIS;

EID: 0030859781     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900100094013     Document Type: Article

References (28)

1. American Joint Committee on Cancer. Manual for Staging of Cancer. Philadelphia, Pa: JB Lippincott; 1992.
2. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer. 1996;77:834-842.
3. Deleyiannis FW-B, Thomas DB, Vaughan TL, Davis S. Alcoholism. J Natl Cancer Inst. 1996;88:542-549.
4. Bailey BJ. Beyond the 'new' TNM classification. Otolaryngol Head Neck Surg. 1991; 117:369-370.
5. Burke HB, Henson DE. Criteria for prognostic factors and for an enhanced prognostic system. Cancer. 1993;72:3131-3135.
6. Neel HB, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol. 1985;94:529-537.
7. Feinstein AR, Schimpft CR, Andrews JF Jr, Wells CK. Cancer of the larynx. J Chronic Dis. 1977;30:277-305.
8. Wells CK, Stoller JK, Feinstein AR, Horwitz RI. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med. 1984;144:2004-2009.
9. Clemens JD, Feinstein AR, Holabird N, Cartwright S. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer. J Chronic Dis. 1986;39:913-928.
10. Feinstein AR. Symptoms as an index of biological behaviour and prognosis in human cancer. Nature. 1966;209:241-245.
11. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Ann Otol Rhinol Laryngol. 1994;103:83-92.
12. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine (Baltimore). 1990;69:1-33.
13. Feinstein AR, Pritchett JA, Schimpft CR. The epidemiology of cancer therapy, II: the clinical course: data, decisions, and temporal demarcations. Arch Intern Med. 1969;123:323-344.
14. Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy, III: the management of imperfect data. Arch Intern Med. 1969;123:448-461.
15. Feinstein AR. Taxonorics, II: formats and coding systems for data processing. Arch Intern Med. 1970;126:1053-1067.
16. Greenfield S, Aronow HU, Elashoff RM, Watanbe D. Flaws in mortality data: the hazards of ignoring comorbid disease. JAMA. 1988;260:2253-2255.
17. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455-469.
18. Satariano WA, Ragland OR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104-110.
19. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87:417-426.
20. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Ois. 1974;27:387-404.
21. Lemeshow S, Hosmer D. Applied Logistic Regression Analysis. New York, NY: John Wiley & Sons Inc; 1989.
22. Walter SD, Feinstein AR, Wells CK. A comparison of multivariable mathematical methods for predicting survival, II: statistical selection of prognostic variables. J Clim Epidemiol. 1990;43:349-359.
23. Feinstein AR. Clinical biostatistics, XV: the process of prognostic stratification, I. Clin Pharmacol Ther. 1972;13:442-457.
24. Iezzoni LI. Risk and outcomes. In: Iezzoni LI, ed. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor, Mich: Health Administration Press; 1994:1-28.
25. Neel HB, Taylor WF. New staging system for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1989;115:1293-1303.
26. Feinstein AR. On classifying cancers while treating patients. Arch Intern Med. 1985;145:1789-1791.
27. Hooley R, Levine H, Flores TC, Wheeler T, Steiger E. Predicting postoperative head and neck complications using nutritional assessment: the Prognostic Nutritional Index. Arch Otolaryngol Head Neck Surg. 1983;109:83-85.
28. Wolf GT, Carey TE, Schmaltz SP, et al. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 1990; 82:1566-1572.